Cargando…

Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study

Immune checkpoint inhibitors (ICIs) elicit antitumour effects by activating the host immunity and cause immune-related adverse events (irAEs). ICI-related interstitial lung disease (ICI-ILD) is a fatal irAE that is difficult to treat; moreover, its incidence is relatively higher in patients with lun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okada, Naoto, Matsuoka, Rie, Sakurada, Takumi, Goda, Mitsuhiro, Chuma, Masayuki, Yagi, Kenta, Zamami, Yoshito, Nishioka, Yasuhiko, Ishizawa, Keisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426925/ https://www.ncbi.nlm.nih.gov/pubmed/32792640 http://dx.doi.org/10.1038/s41598-020-70743-2

Ejemplares similares

Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments
por: Nawa, Hideki, et al.
Publicado: (2021)

Evaluation of Potential Complications of Interstitial Lung Disease Associated With Antiandrogens Using Data From Databases Reporting Spontaneous Adverse Effects
por: Nawa, Hideki, et al.
Publicado: (2021)

Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects
por: Nawa, Hideki, et al.
Publicado: (2022)

Preventive Effects of Quercetin against the Onset of Atherosclerosis-Related Acute Aortic Syndromes in Mice
por: Kondo, Masateru, et al.
Publicado: (2020)

Investigation of drugs affecting hypertension in bevacizumab‐treated patients and examination of the impact on the therapeutic effect
por: Yagi, Kenta, et al.
Publicado: (2020)

Discovery of preventive drugs for cisplatin‐induced acute kidney injury using big data analysis
por: Kanda, Masaya, et al.
Publicado: (2022)

Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study
por: Sakurada, Takumi, et al.
Publicado: (2022)

Effects of 5‐HT(₃) receptor antagonists on cisplatin‐induced kidney injury
por: Goda, Mitsuhiro, et al.
Publicado: (2021)

Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database
por: Okada, Naoto, et al.
Publicado: (2018)

Drug-Repositioning Approaches Based on Medical and Life Science Databases
por: Zamami, Yoshito, et al.
Publicado: (2021)

Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage
por: Yoshioka, Toshihiko, et al.
Publicado: (2023)

Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis( )
por: Chuma, Masayuki, et al.
Publicado: (2022)

Kamishoyosan and Shakuyakukanzoto promote recovery from paclitaxel-induced neurite retraction in PC12 cells
por: Konaka, Ken, et al.
Publicado: (2017)

Search for Therapeutic Agents for Cardiac Arrest Using a Drug Discovery Tool and Large-Scale Medical Information Database
por: Zamami, Yoshito, et al.
Publicado: (2019)

A web-based survey of educational opportunities of medical professionals based on changes in conference design during the COVID-19 pandemic
por: Yagi, Kenta, et al.
Publicado: (2022)

Status of Institutional Review Board Meetings Conducted Through Web Conference Systems in Japanese National University Hospitals During the COVID-19 Pandemic: Questionnaire Study
por: Yagi, Kenta, et al.
Publicado: (2020)

Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor‐induced interstitial lung disease in patients with non‐small cell lung cancer
por: Murata, Daiki, et al.
Publicado: (2022)

Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia
por: Sato, Shiho, et al.
Publicado: (2017)

A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
por: Imakura, Takeshi, et al.
Publicado: (2023)

Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease
por: Otsuka, Kenji, et al.
Publicado: (2022)

Clinical Impact of a Pharmacist-Driven Prospective Audit with Intervention and Feedback on the Treatment of Patients with Bloodstream Infection
por: Okada, Naoto, et al.
Publicado: (2022)

Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers
por: Shimoji, Kiyofumi, et al.
Publicado: (2020)

Comparison of Hemorrhagic Risk between Prasugrel and Clopidogrel: a Retrospective Study using Adverse Drug Event Reporting Databases
por: Hagiwara, Hiromi, et al.
Publicado: (2020)

Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies
por: Matsumoto, Kinnosuke, et al.
Publicado: (2022)

Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease
por: Sato, Yusuke, et al.
Publicado: (2021)

Possibility of Interstitial Lung Disease as a Phlebosclerotic Colitis Manifestation
por: Takemura, Tomoyasu, et al.
Publicado: (2018)

Evaluation of pharmaceutical lifesaving skills training oriented pharmaceutical intervention
por: Zamami, Yoshito, et al.
Publicado: (2016)

Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis
por: Horinouchi, Yuya, et al.
Publicado: (2018)

Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
por: Sato, Shintaro, et al.
Publicado: (2020)

Sensitivity of transbronchial lung cryobiopsy in the diagnosis of different interstitial lung diseases
por: Zaizen, Yoshiaki, et al.
Publicado: (2022)

Lung transplantation for interstitial lung disease
por: Kapnadak, Siddhartha G., et al.
Publicado: (2021)

Interstitial Lung Disease
Publicado: (1982)

Interstitial Lung Diseases
por: Mueller-Mang, Christina, et al.
Publicado: (2009)

Interstitial Lung Diseases
por: Mueller-Mang, Christina, et al.
Publicado: (2017)

Interstitial lung disease
por: Antoniou, Katerina M., et al.
Publicado: (2014)

Association of the RPA3-UMAD1 locus with interstitial lung diseases complicated with rheumatoid arthritis in Japanese
por: Shirai, Yuya, et al.
Publicado: (2020)

Small‐cell lung cancer from the peripheral lung is frequently accompanied by emphysema and interstitial lung disease in the background
por: Ikematsu, Yuki, et al.
Publicado: (2022)

Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
por: Zhou, Qian, et al.
Publicado: (2023)

Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer
por: Sugano, Teppei, et al.
Publicado: (2020)

Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
por: Takeuchi, Eiji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32ed4lr3k7n9rqian83n9uc8f8